
Results from FIDELIO-DKD suggest finerenone was associated with reductions in progression of chronic kidney disease and potential improvements in cardiovascular health.

Results from FIDELIO-DKD suggest finerenone was associated with reductions in progression of chronic kidney disease and potential improvements in cardiovascular health.

The double-blind trial reported on long-term cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.

An analysis of more than 1 million singleton births in Denmark is detailing a potential association between maternal diabetes and increased risk of developing an eating disorder early in life.

Patients who are prescribed metformin may face a risk of urticaria, though the latter can be treated with antihistamines.

Check out this Emergency Department Minute Quiz from Brady Pregerson, MD. Can you determine the correct diagnosis?

Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition.

An analysis of data from a California health survey suggests non-obese Vietnamese Americans were 60% more likely to have diabetes as their non-obese non-Hispanic White counterparts.

An analysis of a Swedish obesity study with more than 20 years of follow-up data is detailing differences in life expectancy among patients who undergo bariatric surgery versus those opting for usual care.

An analysis of data from more than 9 million women details the increased odds of developing gestational diabetes, gestational hypertension, and other complications associated with having polycystic ovary syndrome.

A study presented at UEG Week 2020 suggests a minimally-invasive, outpatient procedure combined with GLP-1 RA therapy could help diabetics eliminate the need for insulin therapy.

An analysis of Explorys data presented at UEG Week 2020 suggests bariatric surgery in obese diabetics could reduce risk of pancreatic cancer.

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

An analysis of data from DiRECT suggests diabetes remission was linked to restoration of pancreas size and function.

An analysis of the Look AHEAD Study suggests improved blood sugar control was linked to improved executive function and neurologic health among patients with type 2 diabetes.

How good are your diagnostic skills? Test them with this month's Visual Dx quiz!

Muthiah Vaduganathan, MD, MPH, of Brigham and Women's discusses the barriers to preventing optimal prescribing practices for SGLT2 inhibitor and GLP-1 receptor agonist therapies.

An analysis of nationally representative data suggests 35.6% of diabetic patients reported not receiving a yearly influenza vaccination.

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

Ongoing trials are essential to confirming semalutide’s role in decreasing risk of chronic kidney disease in patients with type 2 diabetes

An analysis of data from 5 major databases suggests NRTIs could reduce incidence of type 2 diabetes.

An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.